Company Overview

Company name: Ovation Science
Description: Developer of a drug delivery system designed to provide topical and trans-dermal cannabis ancillary technology to market. The company’s system utilizes invisicare polymer to combine hydrophilic and hydrophobic polymers into stable complexes in water emulsions and enhance products function on the skin, enabling customers to get skin friendly and solvent free topical skin products.
Year founded: 2017
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Website: www.ovationscience.com
Employees:
City: Vancouver
State: British Columbia
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 0.10
Business status: Startup
Ownership: Privately Held (backing)
Exchange:
Ticker:
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company raised $100,000 of convertible debt financing from undisclosed investors on August 29, 2018.
Number of active investors:
Profile last updated: 30-Oct-2018
Last known valuation:
Last known valuation date: